Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Hair growth is influenced by factors like genetics and nutrition, and more research is needed to understand hair loss and growth mechanisms.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Finasteride use can cause lasting negative effects like sexual dysfunction, depression, anxiety, and cognitive issues.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Most types of hair loss can regrow naturally, but there are no effective cures for male pattern or age-related hair loss, and only limited options for females.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Flaxseed crackers can help reduce symptoms of PCOS in young women.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.